NorthCrest Asset Manangement LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,639 shares of the healthcare conglomerate's stock after purchasing an additional 2,068 shares during the period. NorthCrest Asset Manangement LLC's holdings in UnitedHealth Group were worth $7,294,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Community Trust & Investment Co. lifted its stake in shares of UnitedHealth Group by 4.2% during the 2nd quarter. Community Trust & Investment Co. now owns 61,680 shares of the healthcare conglomerate's stock valued at $19,242,000 after buying an additional 2,495 shares in the last quarter. Atticus Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 101.9% in the second quarter. Atticus Wealth Management LLC now owns 731 shares of the healthcare conglomerate's stock worth $228,000 after acquiring an additional 369 shares during the period. Mn Services Vermogensbeheer B.V. raised its stake in shares of UnitedHealth Group by 0.6% during the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 342,000 shares of the healthcare conglomerate's stock valued at $106,694,000 after purchasing an additional 2,000 shares during the period. High Net Worth Advisory Group LLC increased its position in shares of UnitedHealth Group by 25.8% during the second quarter. High Net Worth Advisory Group LLC now owns 1,318 shares of the healthcare conglomerate's stock valued at $412,000 after buying an additional 270 shares during the period. Finally, Alecta Tjanstepension Omsesidigt boosted its position in shares of UnitedHealth Group by 84.1% in the second quarter. Alecta Tjanstepension Omsesidigt now owns 400,500 shares of the healthcare conglomerate's stock valued at $124,880,000 after acquiring an additional 183,000 shares during the period. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
UNH traded down $6.87 during mid-day trading on Thursday, reaching $334.74. 11,204,831 shares of the company traded hands, compared to its average volume of 13,853,371. The stock has a market capitalization of $303.16 billion, a P/E ratio of 14.50, a P/E/G ratio of 2.23 and a beta of 0.45. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company's fifty day moving average price is $295.01 and its 200-day moving average price is $366.14.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the firm earned $6.80 EPS. The business's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.
Wall Street Analysts Forecast Growth
UNH has been the subject of a number of recent analyst reports. HSBC reaffirmed a "reduce" rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Barclays boosted their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. Finally, Truist Financial boosted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research note on Tuesday, September 9th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $358.95.
View Our Latest Stock Analysis on UnitedHealth Group
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.